Unknown

Dataset Information

0

Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity.


ABSTRACT: Therapeutic options for treating Mycobacterium abscessus infections are extremely limited; quinolones are important. The in vitro anti-M. abscessus activities of nine quinolones, emphasizing sitafloxacin, were investigated. Antimicrobial susceptibility testing was performed on 10 non-tuberculous mycobacterium reference strains and 194 clinical, M. abscessus isolates. The activity of sitafloxacin against intracellular M. abscessus residing within macrophages was also evaluated. A checkerboard assay was conducted to determine synergy between sitafloxacin and 10 clinically important antibiotics. Among the nine quinolones tested, sitafloxacin exhibited the greatest anti-M. abscessus activity with MIC50 and MIC90 of 1 and 2 mg/L, respectively. Sitafloxacin exerted a bacteriostatic effect on M. abscessus and inhibited the intracellular growth of M. abscessus at concentrations equivalent to clarithromycin. No antagonism between sitafloxacin and 10 clinically important anti-M. abscessus antibiotics was evident. In summary, sitafloxacin exhibited a significant advantage relative to other quinolones in inhibiting the growth of M. abscessus in vitro, suggesting the potential inclusion of sitafloxacin in new strategies to treat M. abscessus infections.

SUBMITTER: He S 

PROVIDER: S-EPMC8770805 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9487484 | biostudies-literature
| S-EPMC9866335 | biostudies-literature
| S-EPMC7181020 | biostudies-literature
| S-EPMC6658768 | biostudies-literature
| S-EPMC8693020 | biostudies-literature
| S-EPMC8571776 | biostudies-literature
| S-EPMC4694086 | biostudies-other
| S-EPMC5571369 | biostudies-literature
| S-EPMC3911466 | biostudies-literature
| S-EPMC8700351 | biostudies-literature